Xermelo (Lexicon Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Xermelo drug offered from Lexicon Pharmaceuticals, Inc.. This Tryptophan Hydroxylase Inhibitor [EPC],Tryptophan Hydroxylase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lexicon Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | telotristat ethyl |
| SUBSTANCE NAME: | TELOTRISTAT ETHYL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Tryptophan Hydroxylase Inhibitor [EPC],Tryptophan Hydroxylase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-03-01 |
| END MARKETING DATE: | 0000-00-00 |
Xermelo HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xermelo from Lexicon Pharmaceuticals, Inc. |
| LABELER NAME: | Lexicon Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2017-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70183-125_bc19dd6b-f00d-4ea4-b92b-68fc2836c1eb |
| PRODUCT NDC: | 70183-125 |
| APPLICATION NUMBER: | NDA208794 |
Other TELOTRISTAT ETHYL Pharmaceutical Manufacturers / Labelers:
